Charcot-Marie-Tooth Disease Recessive Intermediate A (CMTRIA)

Charcot-Marie-Tooth disease recessive intermediate A (CMTRIA) is a rare inherited nerve disease that damages the long nerves in the arms and legs. These nerves carry signals from the brain and spinal cord to the muscles (motor nerves) and bring back feeling from the skin (sensory nerves).MalaCards+1

Charcot–Marie–Tooth (CMT) disease recessive intermediate A is a very rare genetic nerve disease. It belongs to a group called recessive intermediate CMT (CMTRI). In this group, both copies of a gene are changed (autosomal recessive), and nerve test results are “intermediate,” not clearly demyelinating and not clearly axonal. This leads to slowly increasing weakness, muscle wasting, and numbness, especially in the feet and hands.Orpha.net+1

In CMTRIA, the damage is “intermediate.” This means the nerve problem is in-between the two main patterns seen in CMT: one pattern where the insulation (myelin) around the nerve is mainly damaged (demyelinating) and another pattern where the center wire of the nerve (axon) is mainly damaged (axonal). So doctors see mixed signs of both myelin and axon damage when they test the nerves.Muscular Dystrophy Association+1

CMTRIA usually starts in early childhood. Children may walk late, trip often, and develop foot deformities such as high-arched feet or inward-turned feet (clubfoot or pes equinovarus). Over time, weakness and muscle wasting spread from the lower legs to the hands and lower arms, causing problems with walking, running, handwriting, and fine hand tasks.MalaCards+2Orpha.net+2

This disease happens because of changes (mutations) in a gene called GDAP1. The GDAP1 gene helps control the shape and health of tiny energy factories in the cell called mitochondria, especially in nerve cells. When GDAP1 does not work properly, long nerves slowly become sick and stop working well, leading to weakness, loss of sensation, and deformities.MalaCards+2PMC+2

CMTRIA is inherited in an autosomal recessive way. This means a child gets one faulty GDAP1 gene from each parent. The parents are usually healthy carriers and do not have symptoms, but when both pass the changed gene to the same child, that child develops the disease.MedlinePlus+2MedlinePlus+2

Other names

Doctors and researchers use several names for Charcot-Marie-Tooth disease recessive intermediate A. These names all point to the same condition or very closely related descriptions:MalaCards+2Monarch Initiative+2

• Autosomal recessive intermediate Charcot-Marie-Tooth disease type A

• CMTRIA (short code used in scientific and medical texts)

• Charcot-Marie-Tooth disease, recessive intermediate A

• Autosomal recessive intermediate CMT due to GDAP1 mutation

• Hereditary motor and sensory neuropathy, autosomal recessive intermediate type A

These different names highlight that this is:

1. a Charcot-Marie-Tooth (CMT) disease,

2. autosomal recessive,

3. “intermediate” on nerve tests, and

4. linked to the GDAP1 gene.Wikipedia+2Neuroscience Bulletin+2

Types

There is only one official genetic type of CMTRIA (caused by recessive GDAP1 mutations), but doctors may still describe clinical “types” or patterns to show how the disease behaves in different people. These are not separate diseases, but they help explain the range of severity.PubMed+1

• Early-onset severe type
  In some children, symptoms start very early (often before 4 years). They may walk late, trip constantly, and show strong foot deformities such as pes equinovarus. Muscle wasting in the lower legs appears fast, and by the late teenage years many patients may need a wheelchair or walking aids.PubMed+2Orpha.net+2

• Classic childhood-onset type
  In this pattern, children may walk at a normal age but start to stumble in early school years. They develop thin lower legs (“stork legs”), high arches, and hammer toes. Hand weakness appears a bit later, with problems in writing, drawing, or buttoning clothes. Progression is steady over childhood and teenage years.MalaCards+2Global Genes+2

• Juvenile or adolescent type
  Some people develop symptoms mainly in late childhood or teen years. The disease may be milder at the beginning, with slow progression. They can often walk independently for longer and may not need a wheelchair until much later, if at all. However, nerve tests still show the mixed intermediate pattern.Muscular Dystrophy Association+2Neuroscience Bulletin+2

• Type with marked vocal cord involvement
  In some families with GDAP1 mutations, hoarseness and weakness of the vocal cords (vocal cord paresis) are very clear. The voice becomes rough, soft, or breathy. This happens because the nerves that move the vocal cords are also affected by the neuropathy.MalaCards+2Frontiers+2

• Type with mainly lower-limb involvement at first
  Many people first notice symptoms only in the feet and lower legs. Problems in the hands may appear several years later. This “length-dependent” pattern occurs because the longest nerves (to the feet) are usually affected first and most strongly, and then the shorter nerves (to the hands) follow.Frontiers+2Global Genes+2

Causes

The direct cause of CMTRIA is mutation in the GDAP1 gene, but doctors also describe related mechanisms and risk situations. Below are 20 simple “cause-related” points that together explain why this disease happens and what increases the chance that it appears in a family.

1. Recessive GDAP1 gene mutation
   CMTRIA happens when both copies of the GDAP1 gene (one from each parent) carry harmful changes. These changes stop GDAP1 from working properly and lead to neuropathy.MalaCards+1

2. Loss of GDAP1 protein function
   The GDAP1 protein normally sits on the outer membrane of mitochondria and helps control their shape and fission (splitting). When the protein does not work, mitochondria become abnormal, and nerve cells cannot keep their long axons healthy.PMC+2Rockefeller University Press+2

3. Autosomal recessive inheritance pattern
   Because CMTRIA is autosomal recessive, a child must receive a mutated GDAP1 gene from both parents. If only one faulty copy is present, the person is usually a healthy carrier and has no symptoms.MedlinePlus+1

4. Carriers in the family
   When both parents are carriers of a GDAP1 mutation, each pregnancy has a 25% chance of producing a child with CMTRIA, a 50% chance of a carrier child, and a 25% chance of a child with two normal copies.MedlinePlus+1

5. Consanguinity (parents related by blood)
   In some reported families, parents are related (for example, cousins). In such marriages, the chance that both parents carry the same rare GDAP1 mutation is higher, increasing the risk of a recessive disease in their children.PubMed+1

6. Specific harmful GDAP1 variants
   Many different mutations in GDAP1 have been described (for example, small insertions or splice-site changes). Some are strongly linked to early, severe intermediate CMT. The exact mutation can influence how severe and how fast the disease is.PubMed+2OUP Academic+2

7. Loss of mitochondrial fission control
   GDAP1 helps mitochondria to divide correctly. When this process fails, mitochondria can become long and unhealthy. Sick mitochondria cannot supply enough energy, especially in long peripheral nerves, which then slowly degenerate.PMC+2Nature+2

8. Disturbed calcium and energy handling in neurons
   Studies show that lack of GDAP1 can change calcium balance and block important energy-producing enzymes in mitochondria. This harms motor and sensory neurons and makes them prone to damage.Nature+1

9. Axonal degeneration of long nerves
   When GDAP1 is not working, the long axons of peripheral nerves gradually shrink and break down. This axonal degeneration leads to muscle weakness and wasting, especially in the feet and hands.Frontiers+2PLOS+2

10. Secondary myelin changes
    Because axons are unhealthy, the myelin sheath that wraps them also suffers. Pathology and nerve conduction tests often show signs of both myelin damage and axon damage, which is why this form is called “intermediate.”Neuroscience Bulletin+2Neuroscience Bulletin+2

11. Length-dependent vulnerability of nerves
    The longest nerves (to the feet) require the most energy and support. In CMTRIA, these long nerves are affected first, causing early foot problems and later hand problems. The “length-dependent” pattern is typical in many inherited neuropathies.Frontiers+2NCBI+2

12. Founder mutations in certain populations
    In some ethnic groups, a particular GDAP1 mutation may be more common because it appeared in an ancestor (founder effect) and was passed down through generations. Families in those groups may show more cases of recessive CMT.Nature+1

13. Compound heterozygous mutations
    Some patients do not have the same mutation on both copies of GDAP1. Instead, they have two different harmful mutations, one on each copy. This is called compound heterozygosity and still causes loss of GDAP1 function.PubMed+1

14. GDAP1’s role in Schwann cells
    GDAP1 is also expressed in Schwann cells, the cells that make myelin in peripheral nerves. When GDAP1 is defective in these cells, it may worsen demyelination and contribute to the mixed intermediate pattern.Rockefeller University Press+1

15. Interaction with other mitochondrial pathways
    GDAP1 interacts with other proteins involved in mitochondrial fusion, fission, and transport. When GDAP1 is mutated, these whole networks can be disturbed, leading to wider mitochondrial dysfunction in peripheral nerves.MDPI+1

16. Early childhood stress on growing nerves
    During early childhood, nerves are still developing and lengthening. If GDAP1 is defective at this stage, developing nerves may be more vulnerable to damage, explaining why many children with CMTRIA show early, severe symptoms.MalaCards+1

17. Absence of other acquired causes
    In many patients, doctors do blood tests and other checks and do not find vitamin deficiency, diabetes, toxins, or immune diseases that could explain the neuropathy. The lack of acquired causes pushes doctors to suspect a genetic cause like GDAP1 mutation.NCBI+1

18. Nerve pathology showing mixed features
    Sural nerve biopsies, when done, often show both demyelinating signs (thinner myelin sheaths) and axonal loss. This pattern fits the known effect of GDAP1 mutations and helps confirm that the gene defect is the root cause.Neuroscience Bulletin+1

19. Genetic clustering of cases in families
    Multiple affected siblings with healthy parents suggest a recessive inheritance. When genetic testing finds the same GDAP1 mutations in all affected children, this supports GDAP1 as the cause.MedlinePlus+2www.elsevier.com+2

20. Animal models showing neuropathy after GDAP1 loss
    Mouse models where GDAP1 is removed develop peripheral neuropathy with motor neuron loss and abnormal neuromuscular junctions. This shows that GDAP1 loss alone is enough to cause nerve disease, supporting its role as the main cause in humans.PLOS+1

Symptoms

Symptoms can differ between people, but common features of CMTRIA include the following:

1. Delayed walking and frequent falls
   Many children with CMTRIA walk later than usual or look clumsy from early childhood. They often trip over small obstacles because their weak ankle muscles cannot lift the front of the foot well.MalaCards+2Orpha.net+2

2. Weakness in feet and lower legs
   The first noticeable problem is usually weakness in the muscles that lift and move the feet. Children may drag their toes, have trouble running, and find stairs difficult. Over time, lower legs become thin due to muscle loss.MalaCards+2Global Genes+2

3. Foot deformities (high arches, pes equinovarus, clubfoot)
   Strong imbalance of muscles around the ankle can pull the foot into abnormal shapes. Patients may develop high arches, inward-turned feet, or fixed clubfoot. These deformities make walking harder and often need braces or surgery.MalaCards+2Orpha.net+2

4. Weakness and wasting of hand muscles
   Later in the disease, the small muscles of the hands become weak and wasted. Children or adults struggle with buttons, zippers, handwriting, using tools, or opening jars. Hands may look thin and bony.MalaCards+2Muscular Dystrophy Association+2

5. Loss of deep tendon reflexes
   When doctors test knee or ankle jerks with a reflex hammer, the responses are often weak or absent. This is a common sign of peripheral neuropathy in CMT, including CMTRIA.Global Genes+2Neuroscience Bulletin+2

6. Numbness or reduced sensation in feet and hands
   Because sensory nerves are involved, patients may feel reduced touch, vibration, or position sense in their feet and later in their hands. They may not feel small injuries, which can lead to unnoticed cuts or blisters.MalaCards+2Global Genes+2

7. Burning, tingling, or neuropathic pain
   Some people experience burning, tingling, pins-and-needles, or electric shock–like pain in their feet and legs. This is called neuropathic pain and comes from irritated or damaged sensory nerves.NCBI+2Wikipedia+2

8. Balance problems and unsteady gait
   Weak ankle muscles and poor sensation in the feet make it hard to keep balance, especially in the dark or on uneven ground. People may walk with a high-stepping gait to avoid tripping (“steppage gait”).Global Genes+2Muscular Dystrophy Association+2

9. Fatigue and reduced stamina
   Because walking and standing require much more effort with weak muscles and deformities, people often feel tired after short distances. They may avoid sports and physical activities because they cannot keep up with others.NCBI+2Muscular Dystrophy Association+2

10. Leg and foot cramps
    Overworked muscles in the legs and feet can go into painful spasms. Cramps often happen at night or after long periods of standing or walking.NCBI+1

11. Hand clumsiness and loss of fine motor skills
    Tasks that need precise finger control, like tying shoelaces, threading a needle, or typing fast, become difficult or impossible for some patients as hand weakness grows.MalaCards+2NCBI+2

12. Hoarse or weak voice (vocal cord paresis)
    Some people with GDAP1-related intermediate CMT develop weakness in the nerves that move the vocal cords. This causes a hoarse, breathy, or soft voice, and they may tire quickly when talking.MalaCards+2Frontiers+2

13. Spinal deformities (scoliosis or kyphosis)
    Chronic muscle imbalance and weakness can affect the spine, leading to sideways curvature (scoliosis) or forward rounding (kyphosis). These changes may cause back pain and breathing issues in severe cases.Charcot-Marie-Tooth Association+2ResearchGate+2

14. Loss of ankle stability and frequent sprains
    Weak muscles and poor sensation make the ankle joint unstable. Patients may sprain their ankles easily and feel unsafe on uneven surfaces.NCBI+1

15. Emotional and social impact
    Living with visible deformities, disability, or the need for braces and wheelchairs can affect confidence and mood. Children may feel different from classmates, and adults may worry about work and independence. Psychological support and support groups can help.NCBI+2Charcot-Marie-Tooth Association+2

Diagnostic tests

Diagnosis of CMTRIA is based on the combination of clinical features, nerve tests, and genetic findings. Doctors also use tests to rule out other causes of neuropathy.

A. Physical exam tests

1. General neurological examination
   The doctor checks muscle strength, tone, reflexes, sensation, and coordination. In CMTRIA they usually find weakness and wasting in distal muscles, absent reflexes, and reduced sensation in a length-dependent pattern.NCBI+2Muscular Dystrophy Association+2

2. Gait and posture assessment
   The doctor watches how the person stands and walks, looking for high-stepping gait, foot drop, difficulty walking on heels or toes, and use of compensating movements to keep balance.Muscular Dystrophy Association+2Global Genes+2

3. Inspection of feet and hands
   The doctor looks for high arches, hammer toes, clubfoot, thin calves, and wasted hand muscles. These visible signs strongly suggest a chronic hereditary neuropathy like CMT.MalaCards+2Orpha.net+2

4. Spine and skeletal exam
   The spine is checked for scoliosis or kyphosis, and joints are checked for contractures or limited motion. Long-standing muscle imbalance in CMT often leads to these skeletal changes.Charcot-Marie-Tooth Association+2NCBI+2

B. Manual (bedside) tests 

5. Manual muscle testing (MRC scale)
   The doctor grades strength of individual muscle groups using resistance (for example, asking the patient to push or pull against the doctor’s hand). In CMTRIA, ankle dorsiflexors and toe extensors are often the weakest early on.NCBI+2Neuroscience Bulletin+2

6. Sensory testing (pin, light touch, vibration, position)
   Simple tools like a pin, cotton, tuning fork, or movement of toes are used to test pain, touch, vibration, and position sense. Reduced vibration and position sense in the feet are common in CMT.NCBI+2Muscular Dystrophy Association+2

7. Romberg test and balance checks
   The patient stands with feet together, first with eyes open then closed. Increased body sway or falling with eyes closed suggests poor deep sensation from the feet, which is common in length-dependent neuropathy.NCBI+2Global Genes+2

8. Functional hand tests (grip and fine motor tasks)
   Grip strength (for example with a dynamometer) and tasks like buttoning or writing are assessed. Difficulty with these tasks reflects weakness and poor coordination of distal hand muscles in CMTRIA.MalaCards+2NCBI+2

C. Lab and pathological tests 

9. Routine blood tests to rule out acquired neuropathies
   Tests such as blood sugar, B12, thyroid function, kidney and liver tests, and autoimmune screens help exclude other common causes of neuropathy (like diabetes or vitamin deficiency). In CMTRIA, these tests are usually normal.NCBI+2www.elsevier.com+2

10. Genetic testing for GDAP1 mutation
    The most important laboratory test is molecular genetic analysis. A blood sample is used to read the GDAP1 gene sequence. Finding two disease-causing mutations in GDAP1 confirms CMTRIA.MalaCards+2ClinVar Miner+2

11. Next-generation sequencing panels for CMT
    Many centers use large gene panels or whole-exome sequencing to test dozens of neuropathy genes at once. GDAP1 is included in these panels, helping find rare recessive forms like CMTRIA.NCBI+2www.elsevier.com+2

12. Sural nerve biopsy (rarely needed now)
    In some older cases or unclear situations, a small piece of a sensory nerve in the leg (sural nerve) is removed and examined under the microscope. In CMTRIA, pathology shows both axonal loss and demyelinating changes, fitting an intermediate pattern. Today, biopsy is used less often because genetic testing is safer and more specific.Neuroscience Bulletin+2Frontiers+2

13. Cerebrospinal fluid (CSF) analysis (to exclude other diseases)
    A lumbar puncture may be done if doctors suspect immune-mediated neuropathy such as CIDP. In hereditary CMT like CMTRIA, CSF protein is usually normal or only mildly raised, helping separate it from acquired inflammatory neuropathies.NCBI+2www.elsevier.com+2

D. Electrodiagnostic tests 

14. Nerve conduction studies (NCS)
    Surface electrodes are placed on the skin to measure how fast and how strong electrical signals travel along peripheral nerves. In CMTRIA, motor nerve conduction velocities are usually in an “intermediate” range (about 25–45 m/s), with reduced response sizes, showing both demyelinating and axonal features.Muscular Dystrophy Association+2Neuroscience Bulletin+2

15. Electromyography (EMG)
    A thin needle electrode is inserted into muscles to record their electrical activity. EMG in CMTRIA shows signs of chronic denervation and reinnervation, meaning motor units are lost and the remaining ones grow larger to compensate.Muscular Dystrophy Association+2Neuroscience Bulletin+2

16. F-wave and late-response studies
    Special parts of nerve conduction tests (F-waves and other late responses) help assess the whole length of the motor pathway. Abnormal F-waves are common in hereditary neuropathies and support widespread motor nerve involvement.Neuroscience Bulletin+2Neuroscience Bulletin+2

17. Sensory nerve conduction studies
    Sensory responses from nerves in the legs and arms are measured. In CMTRIA, sensory nerve action potentials are often reduced or absent, confirming that both motor and sensory fibers are affected.Muscular Dystrophy Association+2Global Genes+2

E. Imaging tests 

18. Plain X-rays of feet and spine
    X-rays can show high arches, hammer toes, or clubfoot, and can also reveal spinal curvature such as scoliosis or kyphosis. This helps plan orthopedic treatment, braces, or surgery but does not show nerve damage directly.Charcot-Marie-Tooth Association+2Global Genes+2

19. MRI of spine or brain (selected cases)
    Magnetic resonance imaging may be used if doctors want to exclude other neurological conditions. In CMT, MRI is usually normal in the brain and spinal cord, which indirectly supports a peripheral nerve disorder as the main problem.NCBI+2MedlinePlus+2

20. Ultrasound of peripheral nerves and muscles
    Neuromuscular ultrasound can show thinning of muscles and sometimes thickening or other changes in peripheral nerves. While not specific for CMTRIA, it can support the diagnosis of chronic neuropathy and guide where to place EMG needles.Frontiers+2Muscular Dystrophy Association+2

Non-Pharmacological Treatments (Therapies and Other Approaches )

Non-pharmacological treatments are non-drug methods, such as therapies, devices, and lifestyle changes. For CMT recessive intermediate A, these are often the most important parts of care.nhs.uk+1

1. Physiotherapy (physical therapy)
Physiotherapy uses exercises and physical techniques to keep muscles strong, flexible, and balanced. The main purpose is to slow muscle wasting, reduce stiffness, and keep joints moving well. The therapist teaches safe stretching, strengthening, and balance exercises that can be done at home. The mechanism is simple: repeated movement and load on muscles and nerves help maintain muscle size, improve blood flow, and keep joints from getting stiff or “fixed.” Good physiotherapy can also reduce pain and lower the risk of falls.Physiopedia+2nhs.uk+2

2. Stretching programs
Regular stretching keeps muscles and tendons long and flexible. In CMT, tight calf and foot muscles can pull joints into deformities, like high arches or toe clawing. Daily stretching of calves, hamstrings, and feet helps prevent contractures. The purpose is to keep the full range of motion in the ankle and toes so walking stays easier. The mechanism is mechanical: gentle, repeated lengthening of muscles and tendons reduces stiffness in connective tissue and limits permanent shortening.nhs.uk+1

3. Strengthening exercises
Targeted strengthening focuses on muscles that are weak but still working, such as hip and thigh muscles when foot muscles are very weak. The goal is not to “cure” the nerve damage but to help stronger muscles support weaker ones. Using light weights or resistance bands a few times each week can improve walking and reduce fatigue. The mechanism is that repeated resistance training signals muscles to grow stronger and coordinate better, which can partly compensate for nerve weakness.Physiopedia+1

4. Balance and proprioception training
CMT reduces sensation in feet, which makes balance poor. Balance training uses simple tasks like standing on one leg while holding a support, heel-to-toe walking, or balance boards under close supervision. The purpose is to train the brain and remaining nerves to use vision and joint sense more effectively. The mechanism is “neuroplasticity”: repeated practice helps the nervous system adapt and improve control, which reduces falls and increases confidence.ScienceDirect

5. Aerobic (cardio) exercise
Low-impact aerobic exercise, such as walking in a pool, cycling, or swimming, helps heart and lung health and reduces tiredness. The aim is to keep overall fitness high, because weak leg muscles work harder and tire quickly. The mechanism is that regular aerobic work improves oxygen delivery to muscles and supports mitochondrial function, which can make daily activity feel easier and improve mood.Physiopedia+1

6. Orthotics and ankle–foot orthoses (AFOs)
Orthotics are shoe inserts and braces like AFOs that support weak ankles and feet. In CMT, foot drop and high arches make walking harder and increase tripping. AFOs hold the ankle in a safer position and help lift the foot. The purpose is to improve walking pattern, reduce energy use, and prevent sprains. The mechanism is mainly mechanical: the brace replaces lost muscle power and stabilizes joints, so the foot lands more safely.Charcot-Marie-Tooth Association+2Charcot-Marie-Tooth Disease+2

7. Custom footwear and orthopedic shoes
Custom shoes can provide extra width, support, and cushioning for shaped or high-arched feet. Rocker soles help push the foot forward when the ankle is weak. The purpose is to improve comfort, reduce pressure areas, and make walking more efficient. The mechanism is through redistribution of pressure and better alignment, so the foot and ankle are less stressed with each step.PubMed+1

8. Hand splints and wrist supports
Some people with CMT have weak hand muscles and loose joints. Soft or rigid splints can support the thumb, wrist, or fingers during fine tasks like writing or typing. The goal is to maintain hand function and reduce pain or overuse. The mechanism is simple: the splint stabilizes joints so small muscles do not have to work as hard, preventing strain and helping you grip more safely.Charcot-Marie-Tooth Disease+1

9. Occupational therapy
Occupational therapists help adapt daily activities such as dressing, cooking, and school or work tasks. They can suggest equipment like adapted cutlery, writing aids, or special keyboards. The purpose is to keep independence in everyday life. The mechanism is by changing the task or the tools used so that weak muscles or poor sensation are less of a barrier, making daily routines safer and less tiring.ScienceDirect

10. Assistive walking devices
Canes, crutches, or walkers may be needed when balance and strength are low, especially outdoors or on uneven ground. The purpose is to prevent falls and allow longer walking distances. These devices work by widening your base of support and sharing the load between arms and legs. This reduces stress on weak ankles and provides extra sensory feedback from the hands.ScienceDirect+1

11. Podiatry and foot care
Regular visits to a podiatrist help manage calluses, nail problems, and skin breakdown. Numb feet may not feel blisters or wounds, which can get infected. The intention is to protect skin and joints in the feet. The mechanism is early detection and treatment: frequent inspection and care prevent small problems from turning into big ulcers or deformities.ScienceDirect+1

12. Pain management with non-drug methods
Non-drug pain relief includes heat or cold packs, massage, relaxation, mindfulness, and gentle yoga. The aim is to reduce chronic pain, improve sleep, and lower stress. These methods act through several mechanisms: they change how nerves send pain signals, relax tense muscles around weak areas, and calm the brain’s response to pain, which can make pain feel less intense.ScienceDirect

13. Cognitive-behavioural therapy (CBT) and psychological support
Living with a chronic nerve disease can cause anxiety or depression. CBT helps you change unhelpful thoughts and behaviours related to pain and disability. The purpose is to improve coping, reduce fear of movement, and support mental health. The mechanism is psychological: by learning new thinking and behaviour patterns, the brain’s emotional response to symptoms becomes less intense, which can also reduce how strong pain feels.ScienceDirect

14. Vocational and school support
As weakness progresses, work or school tasks may need adjustments, such as flexible hours, rest breaks, or ergonomic chairs and desks. The goal is to help you stay active in education or employment. The mechanism is practical: changing workload and environment reduces physical stress, making it possible to keep attending school or working safely.ScienceDirect

15. Respiratory therapy (when needed)
Most people with CMT do not have major breathing problems, but in some severe cases, breathing muscles can weaken. Respiratory therapy includes breathing exercises and sometimes special machines to help at night. The purpose is to keep oxygen and carbon dioxide levels normal and improve sleep quality. The mechanism is support of weakened breathing muscles so the lungs can move more air in and out.ScienceDirect

16. Home safety changes
Simple changes like removing loose rugs, adding grab bars, and improving lighting can reduce falls. The aim is protection of weak ankles and feet. The mechanism is straightforward: fewer obstacles and better support points mean fewer trips and slips, especially when sensation in the feet is poor or balance is affected.ScienceDirect

17. Weight management and healthy lifestyle
Extra body weight makes walking much harder for weak muscles and puts more stress on joints. A healthy diet and regular light exercise help keep weight in a safe range. The mechanism is mechanical and metabolic: lower weight reduces stress on feet and ankles and improves energy levels, making it easier to stay active.ScienceDirect+1

18. Patient education and self-management
Understanding your condition helps you make better daily choices. Education includes learning about safe exercise, foot care, and early signs of complications. The purpose is to empower you and your family. The mechanism is behavioural change: with better knowledge, you are more likely to follow therapy, use braces correctly, and get help early.ScienceDirect

19. Genetic counselling
Because this is an autosomal recessive disease, future family planning may raise questions. Genetic counselling explains inheritance patterns and testing options for family members. The mechanism is informed decision-making: understanding risks helps people plan pregnancies and consider testing if it is available and appropriate.Orpha.net+1

20. Peer support groups and advocacy
Support groups, online communities, and patient organisations for CMT provide emotional support, shared tips, and up-to-date information about research and trials. The purpose is to reduce isolation and improve coping. The mechanism is social: talking with others in a similar situation can decrease stress and motivate people to keep up with therapy and medical visits.Charcot-Marie-Tooth Disease+1

---

Drug Treatments

Right now there is no FDA-approved medicine that cures CMT or directly stops recessive intermediate A type. Treatment focuses on symptoms such as neuropathic pain, cramps, and mood problems, using drugs that are approved for similar nerve pain conditions but used “off label” in CMT. Always remember: dosing and choice of medicine must be decided by a neurologist, especially in children and teenagers.ScienceDirect+1

Below are examples of important drug groups. Many have FDA labels for neuropathic pain (like postherpetic neuralgia or diabetic nerve pain) but not specifically for CMT.FDA Access Data+1

1. Gabapentin
Gabapentin is an anti-seizure drug often used to treat nerve pain. FDA labels show it is approved for postherpetic neuralgia and seizures, and it is widely used for neuropathic pain. Typical adult doses range from 900–3600 mg per day, divided into three doses, adjusted slowly. The purpose in CMT is to reduce burning, shooting, or tingling pain in feet and hands. Its mechanism involves binding to calcium channels in nerve cells and lowering the release of excitatory neurotransmitters, so pain signals are less intense. Common side effects include sleepiness, dizziness, and swelling of legs.FDA Access Data+1

2. Pregabalin
Pregabalin is related to gabapentin and is approved for several neuropathic pain conditions, including diabetic nerve pain and postherpetic neuralgia. It is usually taken twice daily, with starting doses as low as 75 mg per day and increased by the doctor based on response. The purpose in CMT is similar: to calm nerve pain and improve sleep. Like gabapentin, it works by affecting calcium channels in nerves. Side effects can include dizziness, blurred vision, and weight gain.ScienceDirect

3. Duloxetine
Duloxetine is an antidepressant in the SNRI class, approved for diabetic peripheral neuropathic pain and other conditions. It is typically taken once daily, starting around 30 mg and sometimes increased as needed. The purpose in CMT is to help both nerve pain and low mood, which often occur together. The mechanism is boosting serotonin and norepinephrine levels in the brain and spinal cord, which can dampen pain signals. Side effects may include nausea, dry mouth, and sleep changes.ScienceDirect

4. Amitriptyline
Amitriptyline is a tricyclic antidepressant that has been used for many years to treat chronic pain. It is usually taken once at night, starting at very low doses such as 10–25 mg and increased slowly. In CMT, it can help with nerve pain and sleep problems. It works by blocking reuptake of serotonin and norepinephrine and by blocking certain pain-related receptors. Side effects include dry mouth, constipation, and drowsiness, so it must be used carefully, especially in younger people.ScienceDirect

5. Nortriptyline
Nortriptyline is a related tricyclic antidepressant that may cause fewer side effects than amitriptyline for some people. It is also used at low doses at night for neuropathic pain. Its purpose and mechanism are similar, but some patients tolerate it better. Side effects can still include dry mouth, dizziness, and heart rhythm effects, so monitoring is important.ScienceDirect

6. Carbamazepine or oxcarbazepine
These anti-seizure drugs are sometimes used when nerve pain is shooting or electric-shock-like. Doses vary depending on age and other medicines. The main purpose is to control bursts of pain. They work mainly by blocking sodium channels in nerve cells, which reduces rapid firing of pain pathways. Side effects can include dizziness, low sodium levels, and rarely blood or liver problems, so regular blood tests may be needed.ScienceDirect

7. Topical lidocaine (patch or cream)
Lidocaine patches or creams are placed on painful skin areas. They provide local numbing and are often used for focal neuropathic pain. The purpose in CMT is to reduce surface burning or allodynia without affecting the whole body. The mechanism is blocking sodium channels in the small nerve endings in the skin, so pain signals do not travel as easily to the brain. Side effects are usually mild, such as skin irritation.ScienceDirect

8. Topical capsaicin
Capsaicin cream or patches use chili pepper extract to reduce local nerve pain. At first it may cause burning, but over time it reduces the sensitivity of the pain fibres. The purpose is to treat small, well-defined painful areas. Its mechanism is desensitising TRPV1 receptors in pain nerves, which reduces signal strength. Side effects include temporary burning or redness in the area.ScienceDirect

9. NSAIDs (ibuprofen, naproxen)
Non-steroidal anti-inflammatory drugs do not treat nerve damage itself, but they can reduce musculoskeletal pain from overworked joints and muscles. They are used at standard over-the-counter or prescription doses for short periods. The mechanism is blocking COX enzymes and reducing inflammatory prostaglandins. Side effects can include stomach irritation, ulcers, and kidney strain, especially with long-term use.ScienceDirect

10. Tramadol (careful short-term use)
Tramadol is a weak opioid with additional effects on serotonin and norepinephrine. It may be used for short periods in severe pain that does not respond to other treatments. The purpose is rescue pain control, not daily long-term use. The mechanism is partial opioid receptor activation and monoamine reuptake inhibition. Side effects include nausea, dizziness, constipation, and risk of dependence or withdrawal, so strict medical supervision is essential.ScienceDirect

11. Baclofen
Baclofen is a muscle relaxant used for spasticity and sometimes cramps. In CMT, some people have painful muscle spasms or cramps, and baclofen can be tried at low doses several times a day. It works on GABA-B receptors in the spinal cord to reduce over-active reflexes. Side effects include sleepiness and weakness if the dose is too high.ScienceDirect+1

12. Tizanidine
Tizanidine is another antispastic medicine that can help with cramps and muscle tightness. It acts on alpha-2 adrenergic receptors to reduce the release of excitatory transmitters in the spinal cord. The purpose is to ease stiffness and spasm so movement is easier. Side effects include drowsiness and low blood pressure, so doses must be adjusted carefully.ScienceDirect

13. Botulinum toxin injections
In some cases with very tight muscles causing deformity or pain, botulinum toxin injections may be used. They temporarily weaken specific muscles by blocking acetylcholine at the neuromuscular junction. The purpose is to reduce spasm and improve positioning. The effect lasts a few months and then may need repeating. Side effects depend on the injection site and can include temporary weakness.ScienceDirect

14. Antidepressants and anti-anxiety medicines (SSRIs, SNRIs)
Living with chronic disease can cause depression and anxiety. SSRIs or SNRIs may be prescribed at standard psychiatric doses. Their primary purpose is mood stabilisation, but they can also indirectly reduce pain intensity by improving sleep and coping. Mechanisms involve increasing serotonin and sometimes norepinephrine in the brain. Side effects vary but can include nausea, sleep changes, and, rarely, bleeding risks.ScienceDirect

15–20. Research and orphan-designated drugs (no routine clinical use yet)
Several experimental drugs have received FDA orphan drug designations or are in trials for CMT, such as combinations including baclofen, naltrexone and sorbitol for CMT1A, investigational drugs like NMD670, EN001, and govorestat (AT-007) for certain CMT subtypes. These medicines are still under study and not standard treatments. Their purpose is to target specific disease pathways, such as neuromuscular transmission or metabolic defects. Mechanisms involve specialised molecular targets, and doses are determined only within clinical trials. Outside a trial, they should not be used, and patients interested in them should discuss clinical research options with their neurologist.Charcot-Marie-Tooth Association+4FDA Access Data+4Pharmafile+4

---

Dietary Molecular Supplements

There is no supplement that cures CMT recessive intermediate A. Some nutrients may support nerve and muscle health. Evidence is limited, and doses must always be checked with a doctor to avoid harm.ScienceDirect

1. Vitamin B12
Vitamin B12 is essential for myelin, the insulating layer around nerves. In people with deficiency, B12 replacement can improve nerve function. In CMT, it does not fix the genetic problem but may prevent extra damage from low B12. Typical adult replacement doses vary from 500–1000 micrograms orally daily or injections as prescribed. The function is to support DNA synthesis and myelin formation. Mechanism: it acts as a cofactor in methylation reactions important for nerve cell maintenance.

2. Vitamin B1 (thiamine)
Thiamine is needed for energy production in nerve cells. If thiamine is low, nerves can be more vulnerable. Supplementation at safe doses, such as 50–100 mg/day under medical advice, may support general nerve health. Its function is to help enzymes that use glucose to make ATP. The mechanism is improved mitochondrial energy production, which may help nerves cope better with genetic stress.

3. Vitamin D
Vitamin D supports bone strength and immune function. Weak muscles and altered gait increase fracture risk, so good bone health is important. Typical doses range from 600–2000 IU/day, depending on blood levels. Function: it helps calcium absorption and bone mineralisation. Mechanism: it acts on vitamin D receptors in the intestine and bone cells, improving calcium balance and possibly muscle strength.

4. Omega-3 fatty acids (fish oil)
Omega-3 fatty acids (EPA and DHA) have anti-inflammatory and membrane-stabilising effects. They may help general cardiovascular and brain health. Usual supplemental doses are 500–1000 mg of combined EPA/DHA daily, taken with food. Function: they integrate into cell membranes, making them more flexible. Mechanism: they also shift the balance toward anti-inflammatory eicosanoids, which may slightly improve pain and fatigue.

5. Alpha-lipoic acid
Alpha-lipoic acid is an antioxidant used in some countries for diabetic neuropathy. Typical supplemental doses are around 300–600 mg/day, but must be supervised. Function: it helps neutralise free radicals and support mitochondrial enzymes. Mechanism: by reducing oxidative stress, it may protect nerves from additional damage, although evidence in CMT is limited.

6. Acetyl-L-carnitine
Acetyl-L-carnitine helps transport fatty acids into mitochondria for energy. It has been studied in some neuropathies. Doses often range from 500–1000 mg twice daily in studies, but individual advice is essential. Function: support mitochondrial energy production. Mechanism: it may improve nerve energy supply and promote nerve fibre repair, though data are not strong in CMT.

7. Coenzyme Q10
CoQ10 is part of the mitochondrial electron transport chain. Supplementation, often 100–200 mg/day, may support energy levels, especially if there is a mild mitochondrial issue. Function: improve ATP production and act as an antioxidant. Mechanism: it transfers electrons within mitochondria, reducing oxidative stress and possibly improving muscle endurance.

8. Magnesium
Magnesium is important for nerve conduction and muscle relaxation. In people with low magnesium or cramps, gentle supplementation may help. Doses vary (for example 200–400 mg/day), avoiding excess. Function: cofactor in many enzyme reactions and stabiliser of nerve membranes. Mechanism: it helps regulate calcium channels, which can reduce muscle excitability and cramps.

9. Curcumin (turmeric extract)
Curcumin is an anti-inflammatory compound from turmeric. As a supplement, it is often combined with piperine to improve absorption. Doses vary widely (often 500–1000 mg/day standardized extract), and its evidence in neuropathy is still emerging. Function: reduce inflammation and oxidative stress. Mechanism: curcumin modulates NF-κB and other inflammatory pathways, which might slightly reduce pain and swelling around nerves.

10. Resveratrol or polyphenol mixes
Resveratrol and similar plant polyphenols have antioxidant and anti-inflammatory actions. Supplements usually provide 100–250 mg/day or more, but doses should be discussed with a doctor. Function: protect cells from oxidative stress. Mechanism: they act on signalling pathways like sirtuins and reduce reactive oxygen species, possibly supporting long-term nerve health. Evidence is limited in CMT, so they should be seen as supportive only.

---

Regenerative, Immunity-Related and Stem-Cell-Linked Approaches

At present, there are no approved stem cell or “regenerative” drugs for CMT recessive intermediate A. Some approaches are being studied in early research or animal models. These should only be considered inside controlled clinical trials.ScienceDirect+1

1. Gene therapy – Research aims to deliver a healthy copy of the affected gene (for example genes like GDAP1 or PLEKHG5 in some recessive intermediate CMT types) to nerve cells using viral vectors. The purpose is to correct the basic genetic defect. The mechanism is to allow cells to produce the normal protein, which may stabilise myelin or axons. Doses and schedules are experimental and must only be set within trials.

2. Antisense oligonucleotides (ASOs) – In some CMT subtypes, ASOs are being studied to reduce harmful protein production or modify splicing. The aim is to rebalance protein levels in the nerve. Mechanism: ASOs bind to mRNA and change how it is processed, reducing toxic forms of proteins. This is highly experimental for CMT.

3. Stem-cell-based nerve repair – Research in animals looks at using stem cells to support or replace damaged Schwann cells or neurons. The purpose is to help regrow or myelinate damaged nerves. Mechanism: stem cells may differentiate into supportive cells or release growth factors to promote repair. There is no standard dosage or approved protocol for CMT.

4. Neurotrophic growth factor therapies – Molecules that support nerve survival, such as neurotrophins, are being explored as possible treatments. The aim is to protect axons from degeneration. Mechanism: they bind to specific receptors on nerves and trigger survival signalling. So far, results are mixed and not ready for routine use.

5. Small molecules targeting neuromuscular junction or ion channels – Investigational drugs like NMD670 or others with orphan designations are designed to improve neuromuscular function in CMT. Their purpose is to enhance muscle response to nerve signals. Mechanisms may involve modulation of ion channels or synaptic function. These drugs are not yet approved and are only available in trials.FDA Access Data+3Pharmafile+3CMT Research Foundation+3

6. Immune-modulating approaches – For purely genetic CMT, classic immune-booster drugs or strong immunosuppressants are usually not useful, but research sometimes looks at how inflammation interacts with nerve degeneration. Any such treatments would be highly experimental and used only in special situations, not as standard “immunity boosters.”

---

Surgeries

Surgery does not treat the gene defect. It is used to correct severe deformities that cause pain or make walking very hard. Decisions depend on age, severity, and overall health.ScienceDirect

1. Foot deformity correction (osteotomies)
In CMT, high arches (pes cavus) and claw toes are common. Surgeons may cut and reposition bones in the foot (osteotomy) to make the foot flatter and more stable. The purpose is to improve weight distribution and reduce pain and ankle sprains. The mechanism is structural: by changing bone angles, the foot can sit more evenly on the ground, making braces and shoes more effective.

2. Tendon transfer surgery
If some muscles are strong and others are weak, tendons from stronger muscles can be moved to take over the role of weaker ones, such as lifting the foot. The purpose is to improve active foot dorsiflexion and reduce foot drop. Mechanism: the tendon reroute lets a functioning muscle pull on a new joint, restoring movement that was lost because of nerve damage.

3. Achilles tendon lengthening
Tight Achilles tendons can prevent the heel from touching the ground properly. A lengthening procedure uses small cuts or other techniques to increase tendon length. The purpose is to allow the ankle to bend more and the foot to lie flat. The mechanism is again mechanical: extra length reduces the pull that forces the foot into a tip-toe posture, helping balance and brace fitting.

4. Joint fusion (arthrodesis)
When joints are very unstable and painful, such as the ankle or mid-foot joints, surgeons may fuse them. The purpose is to create a stable, pain-free foot, even if some movement is lost. Mechanism: bone surfaces are prepared and fixed with screws or plates so they grow together as one solid bone, removing the painful joint motion.

5. Scoliosis or hand surgery (when needed)
In a few people, spine curvature (scoliosis) or severe hand deformities may need surgical correction. The goal is to protect lung function, reduce pain, or improve hand function. Mechanisms depend on the procedure but usually involve straightening or stabilizing bones and joints using rods, screws, or tendon releases.

---

Prevention – What Can and Cannot Be Prevented

You cannot prevent the genetic cause of CMT recessive intermediate A. However, you can reduce complications.ScienceDirect+1

1. Early diagnosis and regular follow-up help detect problems before they get severe.

2. Consistent physiotherapy and stretching reduce contractures and joint stiffness.

3. Using braces and proper footwear lowers the risk of falls and injuries.

4. Daily foot inspection and podiatry visits help prevent ulcers and infections.

5. Keeping body weight in a healthy range reduces stress on joints and weak muscles.

6. Avoiding high-impact sports or risky activities prevents fractures and ankle sprains.

7. Staying up-to-date with vaccinations, especially flu and pneumonia shots if breathing muscles are weak, may reduce serious infections.

8. Avoiding known neurotoxic drugs (for example, certain chemotherapy drugs or high-dose Vitamin B6) when possible lowers extra nerve risk; this must be discussed with a neurologist.

9. Managing mood and stress through counselling, support, and healthy routines prevents mental-health complications.

10. Considering genetic counselling when planning a family helps reduce surprise and supports informed reproductive choices.

---

When to See a Doctor

You should see a neurologist or specialist clinic soon after symptoms are noticed, such as frequent tripping, foot deformities, or family history of CMT. Regular check-ups, often once a year or more if symptoms change, help keep treatment updated.ScienceDirect+1

You should seek medical help sooner if you notice new or quickly worsening weakness, more falls, severe or sudden pain, open sores on the feet, breathing problems, trouble swallowing, or major mood changes like deep sadness or thoughts of harming yourself. For any emergency symptoms such as serious breathing difficulty or sudden severe weakness, urgent hospital care is needed.

---

What to Eat and What to Avoid

A special “CMT diet” does not exist, but good nutrition supports muscles, bones, and general health.

Eat more of:
Focus on a balanced diet with plenty of vegetables, fruits, whole grains, lean proteins (fish, chicken, beans, lentils), and healthy fats (olive oil, nuts, seeds). Calcium and vitamin D-rich foods like dairy or fortified plant milks support bone health, which is important when gait is altered. Foods rich in omega-3 fats (fatty fish like salmon, flaxseed, walnuts) may help with inflammation. Slow-release carbohydrates, such as oats and brown rice, give steady energy and may reduce fatigue.

Avoid or limit:
Try to cut back on sugary drinks, sweets, and processed snacks that add calories but no nutrients, because extra weight makes walking harder. Limit very salty and highly processed foods to protect heart and kidney health. Avoid very high doses of supplements without medical advice, especially vitamin B6, which in excess can itself damage nerves. Alcohol should be limited, because heavy drinking can worsen neuropathy. Energy drinks or high-caffeine products may disturb sleep and increase tremor or anxiety.

---

Frequently Asked Questions

1. Is CMT recessive intermediate A curable?
No. At this time, there is no cure that removes the genetic change. Treatment focuses on symptoms: keeping mobility, preventing deformities, and controlling pain. Research on gene therapy and orphan drugs is ongoing, and future treatments may change this, but right now care is supportive.ScienceDirect+2Neuroscience Bulletin+2

2. Will I end up in a wheelchair?
Many people with CMT can walk for most or all of their lives, especially with early braces, physiotherapy, and proper shoes. Some people may need a wheelchair for long distances or later in life. The exact course is different for each person and depends on the gene involved and how early and consistently treatment is used.ScienceDirect+1

3. Is exercise safe for me?
Yes, in most cases gentle, supervised exercise is not only safe but very helpful. The key is low-impact activities like swimming or cycling, and avoiding over-tiredness or high-impact sports. A physiotherapist can design a program that protects weak joints while keeping muscles as strong as possible.Physiopedia+1

4. Can medicines like gabapentin or duloxetine fix my nerves?
These medicines do not repair nerves or change the gene. They help with nerve pain and sometimes with sleep and mood. They are tools to make daily life more comfortable while other therapies work on strength, balance, and function.FDA Access Data+2FDA Access Data+2

5. Are clinical trials worth considering?
Clinical trials test new treatments and can be a way to access promising therapies under close monitoring. They also help advance science for everyone with CMT. However, they may not always help, and they can have unknown risks. You should discuss any trial with your neurologist and family to understand possible benefits and risks.Pharmafile+2Pharmacy Times+2

6. Will CMT recessive intermediate A affect my brain or thinking?
Most forms of CMT, including recessive intermediate types, mainly affect peripheral nerves and muscles, not the brain. Thinking and intelligence are usually normal. Fatigue, pain, and mood changes, however, can affect concentration, so managing symptoms and sleep is important.Orpha.net+1

7. Can children and teenagers have this disease?
Yes. Many recessive intermediate CMT cases start in childhood or adolescence, with early signs such as clumsiness, frequent ankle sprains, or high arches. Early diagnosis allows early therapy, which can improve long-term function.Orpha.net+1

8. Should my family members be tested?
Because this is inherited, siblings may carry the same gene changes. Whether to test depends on age, symptoms, and family wishes. Genetic counselling can explain the pros and cons, such as planning for the future versus anxiety about results.Orpha.net+1

9. Can I have children, and will they have CMT?
People with recessive CMT can have children. If your partner does not carry a change in the same gene, your children will usually be carriers but not affected. If both parents carry a mutation in the same gene, each child has a 25% chance of having the disease. Genetic counselling can explain options such as carrier testing or prenatal diagnosis.Orpha.net+1

10. Does diet really matter for my nerves?
Diet cannot change the gene, but a healthy pattern supports your overall health, weight, bones, and energy. Good nutrition helps you participate in physiotherapy and daily activities. It also lowers risk of other diseases (like diabetes) that could add extra nerve damage.nhs.uk+1

11. Will surgery stop the disease from getting worse?
No. Surgery can correct deformities and improve function or pain, but it does not stop nerve degeneration. Nerves may continue to weaken over time, so braces and therapy are still needed after surgery.ScienceDirect

12. Are “nerve-boosting” or “immunity-boosting” injections safe and useful?
Many products advertised as nerve or immunity boosters are not well-studied and may be expensive or even harmful. For genetic CMT, there is no simple booster injection that fixes the problem. Only evidence-based treatments recommended by your neurologist should be used, and unproven therapies should be avoided outside trials.ScienceDirect+1

13. Can stress make my CMT worse?
Stress does not change the gene, but it can make pain, fatigue, and sleep problems much worse. Over time, this can make you feel weaker and less active. Stress management, counselling, and healthy routines can help you feel better and keep up with therapy.ScienceDirect

14. How often should I see my care team?
Most people benefit from regular reviews with a neurologist once a year and more frequent physiotherapy visits when starting or changing programs. You may also see an orthotist, podiatrist, or surgeon when braces or surgery are being planned. The schedule should be personalised based on symptom changes.ScienceDirect+1

15. Is it my fault that I have this condition?
No. CMT recessive intermediate A is caused by inherited gene changes and is not due to anything you did or did not do. What you can control is how you manage it: staying informed, following therapy, seeking support, and working with your care team can make a real difference in your quality of life.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 24, 2025.